Showing results (271-280 of 523) with videos related to
Sort By:
Pageof 53
Frontiers in Oncology|April 27, 2019
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival MelanomaErnesto Rossi, Brigida Anna Maiorano, Monica Maria Pagliara, et al.Cancer Genetics|October 19, 2016
Mesothelioma families without inheritance of a BAP1 predisposing mutationValeria Ascoli, Ilaria Cozzi, Simona Vatrano, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 15, 2014
Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisisGiovanni Leuzzi, Elisa Meacci, Giacomo Cusumano, et al.World Journal of Gastrointestinal Surgery|October 8, 2021
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinomaIlaria Trestini, Marco Cintoni, Emanuele Rinninella, et al.Breast (Edinburgh, Scotland)|October 18, 2016
Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatmentLaura Orlando, Giuseppe Viale, Emilio Bria, et al.Cancers|July 8, 2020
Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren's Classification in Pan-Cancer Analysis Era?Ina Valeria Zurlo, Michele Basso, Antonia Strippoli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2011
Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancerGiorgio V Scagliotti, Ugo Pastorino, Johan F Vansteenkiste, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 11, 2024
Pathological T3 Non-Small Cell Lung Cancer with satellite nodules: Number or size, what does matter?Pietro Bertoglio, Filippo Tommaso Gallina, Vittorio Aprile, et al.Breast (Edinburgh, Scotland)|February 4, 2026
Predicting progression-free survival in hormone-receptor positive (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors: A machine learning approachSergio Pannunzio, Luca Mastrantoni, Noemi Maliziola, et al.Clinical Genitourinary Cancer|January 18, 2018
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Emilio Bria, et al.Pageof 53